Morin CM, Benca R. Chronic insomnia. Lancet. 2012 Mar;379(9821):1129–41. PMID: WOS:000302131800035. [PubMed: 22265700]

Guideline Development Group for the management of patients in primary care. National Health System Quality Plan, Ministry of Health and Social Policy. Health Technology Assessment Unit; Lain Entralgo Agency;Community of Madrid; 2009. Clinical Practice Guidelines for the Management of Patients with Insomnia in Primary Care.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition. Arlington, VA: American Psychiatric Association; 2013. Sleep-Wake Disorders.

Kyle SD, Morgan K, Espie CA. Insomnia and health-related quality of life. Sleep Med Rev. 2010 Feb;14(1):69–82. [PubMed: 19962922]

Morin CM, Belanger L, LeBlanc M, et al. The natural history of insomnia: a population-based 3-year longitudinal study. Arch Intern Med. 2009 Mar 9;169(5):447–53. [PubMed: 19273774]

Buysse DJ. Insomnia. Jama. 2013 Feb 20;309(7):706–16. [PMC free article: PMC3632369] [PubMed: 23423416]

DynaMed. Insomnia. EBSCO Information Services; 1995. [December 5]. [Internet] Registration and login required.

Montgomery P, Dennis J. Cognitive behavioural interventions for sleep problems in adults aged 60+ Cochrane Database Syst Rev. 2003;(1) CD003161. [PubMed: 12535460]

Xu M, Belanger L, Ivers H, et al. Comparison of subjective and objective sleep quality in menopausal and non-menopausal women with insomnia. Sleep Med. 2011;12(1):65–9. [PubMed: 21147026]

Rybarczyk B, Lund HG, Garroway AM, et al. Cognitive Behavioral Therapy for Insomnia in Older Adults: Background, Evidence, and Overview of Treatment Protocol. Clinical Gerontologist. 2013 Jan;36(1):70–93. PMID: WOS:000312700500005.

Wilson SJ, Nutt DJ, Alford C, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol. 2010 Nov;24(11):1577–601. [PubMed: 20813762]

Smith MT, Huang MI, Manber R. Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disorders. Clin Psychol Rev. 2005 Jul;25(5):559–611. PMID: WOS:000230812200003. [PubMed: 15970367]

Kraus SS, Rabin LA. Sleep America: Managing the crisis of adult chronic insomnia and associated conditions. J Affect Disord. 2012 May;138(3):192–212. PMID: WOS:000302663900002. [PubMed: 21652083]

Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008 Oct 15;4(5):487–504. [PMC free article: PMC2576317] [PubMed: 18853708]

Morgenthaler T, Kramer M, Alessi C, et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An american academy of sleep medicine report. Sleep. 2006 Nov;29(11):1415–9. [PubMed: 17162987]

AASM. Personal Communication. 2013.

Baillargeon L, Landreville P, Verreault R, et al. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. Canadian Medical Association Journal. 2003 Nov;169(10):1015–20. PMID: WOS:000186592000008. [PMC free article: PMC236226] [PubMed: 14609970]

Espie CA. “Stepped care”: a health technology solution for delivering cognitive behavioral therapy as a first line insomnia treatment. Sleep. 2009;32(12):1549–58. [PMC free article: PMC2786038] [PubMed: 20041590]

Buysse DJ. Insomnia. Jama. 309(7):706–16. [PMC free article: PMC3632369] [PubMed: 23423416]

U.S. Food and Drug Administration. Drug@FDA. [March 18, 2015]. www​.accessdata.fda.gov​/scripts/cder/drugsatfda/index.cfm.

Zhao K. Acupuncture for the treatment of insomnia. Int Rev Neurobiol. 2013;111:217–34. [PubMed: 24215925]

Xie CL, Gu Y, Wang WW, et al. Efficacy and safety of Suanzaoren decoction for primary insomnia: a systematic review of randomized controlled trials. BMC Altern Med. 2013;13:18. [PMC free article: PMC3554563] [PubMed: 23336848]

Yeung W-F, Chung K-F, Poon MM-K, et al. Prescription of Chinese herbal medicine and selection of acupoints in pattern-based traditional Chinese medicine treatment for insomnia: a systematic review. Evidence-Based Complementary and Alternative Medicine. 2012;2012 [PMC free article: PMC3521464] [PubMed: 23259001]

Yeung WF, Chung KF, Poon MM, et al. Chinese herbal medicine for insomnia: a systematic review of randomized controlled trials. Sleep Med Rev. 2012 Dec;16(6):497–507. [PubMed: 22440393]

Yeung WF, Chung KF, Poon MM, et al. Acupressure, reflexology, and auricular acupressure for insomnia: a systematic review of randomized controlled trials. Sleep Med. 2012 Sep;13(8):971–84. [PubMed: 22841034]

Fismer KL, Pilkington K. Lavender and sleep: A systematic review of the evidence. European Journal of Integrative Medicine. 2012 Dec;4(4):E436–E47. PMID: WOS:000312093100011.

Cheuk DK, Yeung WF, Chung KF, et al. Acupuncture for insomnia. Cochrane Database Syst Rev. 2012;9 CD005472. [PubMed: 22972087]

Sarris J, Byrne GJ. A systematic review of insomnia and complementary medicine. Sleep Med Rev. 2011 Apr;15(2):99–106. [PubMed: 20965131]

Lee J, Han M, Chung Y, et al. Effects of foot reflexology on fatigue, sleep and pain: a systematic review and meta-analysis. Journal Korean acad. 2011 Dec;41(6):821–33. [PubMed: 22310867]

Ernst E, Lee MS, Choi TY. Acupuncture for insomnia? An overview of systematic reviews. Eur J Gen Pract. 2011 Jun;17(2):116–23. [PubMed: 21463162]

Kleinman L, Buysse DJ, Harding G, et al. Patient-reported outcomes in insomnia: development of a conceptual framework and endpoint model. Behav Sleep Med. 2013;11(1):23–36. [PubMed: 23347114]

Morin CM. Measuring outcomes in randomized clinical trials of insomnia treatments. Sleep Med Rev. 2003 Jun;7(3):263–79. [PubMed: 12927124]

Buscemi N, Vandermeer B, Friesen C, et al. Manifestations and Management of Chronic Insomnia in Adults. Rockville, MD: 2005. (Summary, Evidence Report/Technology Assessment no. 125). (Prepared by the Alberta Evidence-based Practice Center, under Contract No. C400000021.) AHRQ Publication 05-E021-1. [PMC free article: PMC4781279] [PubMed: 15989374]

Carson S, McDonagh M, Thakurta S. Drug Class Reviews. Oregon Evidence-based Practice Center, Oregon Health & Science University; 2008. Drug Class Review: Newer Drugs for Insomnia: Final Report Update 2. [Internet] www​.ncbi.nlm.nih.gov/books/NBK47207. [PubMed: 21089248]

Holbrook AM, Crowther R, Lotter A, et al. Meta-analysis of benzodiazepine use in the treatment of insomnia. Canadian Medical Association Journal. 2000;162(2):225–33. [PMC free article: PMC1232276] [PubMed: 10674059]

Morin CM, Bootzin RR, Buysse DJ, et al. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004). Sleep. 2006 Nov;29(11):1398–414. [PubMed: 17162986]

Morin CM, Hauri PJ, Espie CA, et al. Nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine review. Sleep. 1999 Dec 15;22(8):1134–56. [PubMed: 10617176]

The Cochrane Collaboration. Review Manager(RevMan) [Computer program]. Version 5.2. 2012.

White C, Ip S, McPheeters M, et al. Using existing systematic reviews to replace de novo processes in conducting Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality; 2009. http:​//effectivehealthcare​.ahrq.gov/repFiles​/methodsguide/systematicreviewsreplacedenovo.pdf. [PubMed: 21433402]

Viswanathan M, Ansari M, Berkman N, et al. Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions. AHRQ. 2012

Fu R, Gartlehner G, Grant M, et al. Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program. Journal of Clinical Epidemiology. 2011 Nov;64(11):1187–97. [PubMed: 21477993]

Yang M, Morin CM, Schaefer K, et al. Interpreting score differences in the Insomnia Severity Index: using health-related outcomes to define the minimally important difference. Curr Med Res Opin. 2009 Oct;25(10):2487–94. [PubMed: 19689221]

Revicki D, Hays RD, Cella D, et al. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. Journal of Clinical Epidemiology. 2008 Feb;61(2):102–9. [PubMed: 18177782]

Terwee CB, Roorda LD, Dekker J, et al. Mind the MIC: large variation among populations and methods. Journal of Clinical Epidemiology. 2010 May;63(5):524–34. [PubMed: 19926446]

de Vet HC, Foumani M, Scholten MA, et al. Minimally important change values of a measurement instrument depend more on baseline values than on the type of intervention. Journal of Clinical Epidemiology. 2015 May;68(5):518–24. [PubMed: 25544741]

Dworkin RH, Turk DC, Wyrwich KW, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008 Feb;9(2):105–21. [PubMed: 18055266]

Johnston BC, Patrick DL, Thorlund K, et al. Patient-reported outcomes in meta-analyses-part 2: methods for improving interpretability for decision-makers. Health Qual Life Outcomes. 2013;11:211. [PMC free article: PMC3984637] [PubMed: 24359184]

Omachi TA. Measures of sleep in rheumatologic diseases: Epworth Sleepiness Scale (ESS), Functional Outcome of Sleep Questionnaire (FOSQ), Insomnia Severity Index (ISI), and Pittsburgh Sleep Quality Index (PSQI). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S287–96. [PMC free article: PMC3711174] [PubMed: 22588751]

Berkman ND, Lohr KN, Ansari M, et al. Grading the strength of a body of evidence when assessing health care interventions for the effective health care program of the Agency for Healthcare Research and Quality: an update. 2013

Atkins D, Chang S, Gartlehner G, et al. Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality; 2014. Assessing the applicability of studies when comparing medical interventions; 2010. AHRQ Publication No. 10(14)-EHC063-EF. Chapters available at www​.effectivehealthcare.ahrq.gov.

Arnedt JT, Cuddihy L, Swanson LM, et al. Randomized controlled trial of telephone-delivered cognitive behavioral therapy for chronic insomnia. Sleep. 2013 Mar;36(3):353–62. [PMC free article: PMC3571746] [PubMed: 23450712]

Bjorvatn B, Fiske E, Pallesen S. A self-help book is better than sleep hygiene advice for insomnia: a randomized controlled comparative study. Scand J Psychol. 2011 Dec;52(6):580–5. [PubMed: 21790620]

Bothelius K, Kyhle K, Espie CA, et al. Manual-guided cognitive-behavioural therapy for insomnia delivered by ordinary primary care personnel in general medical practice: a randomized controlled effectiveness trial. J Sleep Res. 2013 Dec;22(6):688–96. [PubMed: 23859625]

Edinger J, Sampson W. A primary care “friendly” cognitive behavioral insomnia therapy. Sleep. 2003;26(2):177–82. [PubMed: 12683477]

Edinger J, Wohlgemuth W, Radtke R, et al. Cognitive behavioral therapy for treatment of chronic primary insomnia: A randomized controlled trial. J Am Med Assoc. 2001;285(14):1856–64. [PubMed: 11308399]

Edinger JD, Olsen MK, Stechuchak KM, et al. Cognitive behavioral therapy for patients with primary insomnia or insomnia associated predominantly with mixed psychiatric disorders: a randomized clinical trial. Sleep. 2009 Apr;32(4):499–510. [PMC free article: PMC2663864] [PubMed: 19413144]

Espie CA, Inglis SJ, Tessier S, et al. The clinical effectiveness of cognitive behaviour therapy for chronic insomnia: implementation and evaluation of a sleep clinic in general medical practice. Behaviour Research and Therapy. 2001 Jan;39(1):45–60. PMID: WOS:000165850000004. [PubMed: 11125723]

Espie CA, Kyle SD, Williams C, et al. A Randomized, Placebo-Controlled Trial of Online Cognitive Behavioral Therapy for Chronic Insomnia Disorder Delivered via an Automated Media-Rich Web Application. Sleep. 2012 Jun;35(6):769–81. PMID: WOS:000304767300015. [PMC free article: PMC3353040] [PubMed: 22654196]

Espie CA, MacMahon KM, Kelly H-L, et al. Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice. Sleep: Journal of Sleep and Sleep Disorders Research. 2007 May;30(5):574–84. [PubMed: 17552372]

Jacobs GD, Pace-Schott EF, Stickgold R, et al. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med. 2004 Sep 27;164(17):1888–96. [PubMed: 15451764]

Jansson M, Linton SJ. Cognitive-behavioral group therapy as an early intervention for insomnia: a randomized controlled trial. Journal of Occupational Rehabilitation. 2005 Jun;15(2):177–90. [PubMed: 15844675]

Jernelov S, Lekander M, Blom K, et al. Efficacy of a behavioral self-help treatment with or without therapist guidance for co-morbid and primary insomnia -a randomized controlled trial. BMC Psychiatry. 2012 Jan 22;12(5) [PMC free article: PMC3328261] [PubMed: 22264332]

Lancee J, van den Bout J, van Straten A, et al. Internet-delivered or mailed self-help treatment for insomnia?: a randomized waiting-list controlled trial. Behav Res Ther. 2012 Jan;50(1):22–9. [PubMed: 22055281]

Mimeault V, Morin CM. Self-help treatment for insomnia: bibliotherapy with and without professional guidance. J Consult Clin Psychol. 1999 Aug;67(4):511–9. [PubMed: 10450621]

Morgan K, Dixon S, Mathers N, et al. Psychological treatment for insomnia in the management of long-term hypnotic drug use: a pragmatic randomised controlled trial. Br J Gen Pract. 2003 Dec;53(497):923–8. [PMC free article: PMC1314744] [PubMed: 14960215]

Morin CM, Beaulieu-Bonneau S, LeBlanc M, et al. Self-help treatment for insomnia: a randomized controlled trial. Sleep. 2005 Oct;28(10):1319–27. [PubMed: 16295218]

Ritterband LM, Thorndike FP, Gonder-Frederick LA, et al. Efficacy of an Internet-based behavioral intervention for adults with insomnia. Archives of General Psychiatry. 2009 Jul;66(7):692–8. [Erratum appears in Arch Gen Psychiatry. 2010 Mar;67(3):311] [PMC free article: PMC3723339] [PubMed: 19581560]

Strom L, Pettersson R, Andersson G. Internet-based treatment for insomnia: a controlled evaluation. J Consult Clin Psychol. 2004 Feb;72(1):113–20. [PubMed: 14756620]

van Straten A, Cuijpers P, Smit F, et al. Self-help treatment for insomnia through television and book: a randomized trial. Patient Educ Couns. 2009 Jan;74(1):29–34. [PubMed: 18801639]

van Straten A, Emmelkamp J, de Wit J, et al. Guided Internet-delivered cognitive behavioural treatment for insomnia: a randomized trial. Psychological Medicine. 2014 May;44(7):1521–32. [PubMed: 24001364]

Vincent N, Lewycky S. Logging on for better sleep: RCT of the effectiveness of online treatment for insomnia. Sleep. 2009 Jun;32(6):807–15. [PMC free article: PMC2690569] [PubMed: 19544758]

Wu R, Bao J, Zhang C, et al. Comparison of sleep condition and sleep-related psychological activity after cognitive-behavior and pharmacological therapy for chronic insomnia. Psychother Psychosom. 2006;75(4):220–8. [PubMed: 16785771]

Morgan K, Gregory P, Tomeny M, et al. Self-help treatment for insomnia symptoms associated with chronic conditions in older adults: a randomized controlled trial. J Am Geriatr Soc. 2012 Oct;60(10):1803–10. [PubMed: 23035962]

Morin C, Colecchi C, Stone J, et al. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. J Am Med Assoc. 1999;281(11):991–9. [PubMed: 10086433]

Morin CM, Kowatch RA, Barry T, et al. Cognitive-behavior therapy for late-life insomnia. J Consult Clin Psychol. 1993 Feb;61(1):137–46. [PubMed: 8450099]

Irwin MR, Olmstead R, Carrillo C, et al. Cognitive behavioral therapy vs. Tai Chi for late life insomnia and inflammatory risk: A randomized controlled comparative efficacy trial. Sleep. 2014 Sep 01;37(9):1543–52. [PMC free article: PMC4153053] [PubMed: 25142571]

Rybarczyk B, Stepanski E, Fogg L, et al. A placebo-controlled test of cognitive-behavioral therapy for comorbid insomnia in older adults. J Consult Clin Psychol. 2005 Dec;73(6):1164–74. [PubMed: 16392989]

Rybarczyk B, Lopez M, Benson R, et al. Efficacy of two behavioral treatment programs for comorbid geriatric insomnia. Psychol Aging. 2002 Jun;17(2):288–98. [PubMed: 12061413]

Vitiello MV, Rybarczyk B, Von Korff M, et al. Cognitive behavioral therapy for insomnia improves sleep and decreases pain in older adults with co-morbid insomnia and osteoarthritis. J Clin Sleep Med. 2009 Aug 15;5(4):355–62. [PMC free article: PMC2725255] [PubMed: 19968014]

Jungquist CR, O'Brien C, Matteson-Rusby S, et al. The efficacy of cognitive-behavioral therapy for insomnia in patients with chronic pain. Sleep Med. 2010 Mar;11(3):302–9. [PMC free article: PMC2830371] [PubMed: 20133188]

Jungquist CR, Tra Y, Smith MT, et al. The durability of cognitive behavioral therapy for insomnia in patients with chronic pain. sleep disord. 2012;2012:679648. [PMC free article: PMC3581267] [PubMed: 23470897]

Pigeon WR, Moynihan J, Matteson-Rusby S, et al. Comparative effectiveness of CBT interventions for co-morbid chronic pain & insomnia: a pilot study. Behav Res Ther. 2012 Nov;50(11):685–9. [PMC free article: PMC3466363] [PubMed: 22982083]

Smith MT, Finan PH, Buenaver LF, et al. Cognitive-behavior therapy for insomnia in knee osteoarthritis: A double-blind, randomized, active placebo controlled clinical trial. Arthritis & Rheumatology. 2015 [PMC free article: PMC6040809] [PubMed: 25623343]

Tang NKY, Goodchild CE, Salkovskis PM. Hybrid cognitive-behaviour therapy for individuals with insomnia and chronic pain: A pilot randomised controlled trial. Behaviour Research and Therapy. 2012 Dec;50(12):814–21. PMID: WOS:000312048400009. [PubMed: 23123531]

McCurry SM, Shortreed SM, Von Korff M, et al. Who benefits from CBT for insomnia in primary care? Important patient selection and trial design lessons from longitudinal results of the Lifestyles trial. Sleep. 2014 Feb;37(2):299–308. [PMC free article: PMC3900626] [PubMed: 24497658]

Vitiello MV, McCurry SM, Shortreed SM, et al. Cognitive-behavioral treatment for comorbid insomnia and osteoarthritis pain in primary care: the lifestyles randomized controlled trial. J Am Geriatr Soc. 2013 Jun;61(6):947–56. [PMC free article: PMC3772673] [PubMed: 23711168]

Jansson-Frojmark M, Linton SJ, Flink IK, et al. Cognitive-behavioral therapy for insomnia co-morbid with hearing impairment: a randomized controlled trial. J Clin Psychol Med Settings. 2012 Jun;19(2):224–34. [PubMed: 22323041]

Taylor DJ, Zimmerman MR, Gardner CE, et al. A pilot randomized controlled trial of the effects of cognitive-behavioral therapy for insomnia on sleep and daytime functioning in college students. Behav. 2014 May;45(3):376–89. [PubMed: 24680232]

Harris J, Lack L, Kemp K, et al. A randomized controlled trial of intensive sleep retraining (ISR): a brief conditioning treatment for chronic insomnia. Sleep. 2012 Jan;35(1):49–60. [PMC free article: PMC3242687] [PubMed: 22215918]

Buysse DJ, Germain A, Moul DE, et al. Efficacy of brief behavioral treatment for chronic insomnia in older adults. Arch Intern Med. 2011 May 23;171(10):887–95. [PMC free article: PMC3101289] [PubMed: 21263078]

Germain A, Moul DE, Franzen PL, et al. Effects of a brief behavioral treatment for late-life insomnia: Preliminary findings. J Clin Sleep Med. 2006 Oct 15;2(4):403–6. [PubMed: 17557467]

McCrae CS, McGovern R, Lukefahr R, et al. Research Evaluating Brief Behavioral Sleep Treatments for Rural Elderly (RESTORE): a preliminary examination of effectiveness. Am J Geriatr Psychiatry. 2007 Nov;15(11):979–82. [PubMed: 17974868]

Soeffing JP, Lichstein KL, Nau SD, et al. Psychological treatment of insomnia in hypnotic-dependant older adults. Sleep Med. 2008 Jan;9(2):165–71. [PMC free article: PMC2330271] [PubMed: 17644419]

Fernando A 3rd, Arroll B, Falloon K. A double-blind randomised controlled study of a brief intervention of bedtime restriction for adult patients with primary insomnia. Journal of Primary Health Care. 2013 Mar;5(1):5–10. [PubMed: 23457689]

Epstein DR, Sidani S, Bootzin RR, et al. Dismantling multicomponent behavioral treatment for insomnia in older adults: a randomized controlled trial. Sleep. 2012 Jun;35(6):797–805. [PMC free article: PMC3353033] [PubMed: 22654199]

Lichstein KL, Riedel BW, Wilson NM, et al. Relaxation and sleep compression for late-life insomnia: A placebo-controlled trial. Journal of Consulting and Clinical Psychology. 2001;69(2):227–39. [PubMed: 11393600]

Espie C, Lindsay W, Brooks D, et al. A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behav Res Ther. 1989;27(1):79–88. [PubMed: 2914008]

Morin CM, Azrin NH. Behavioral and cognitive treatments of geriatric insomnia. Journal of Consulting and Clinical Psychology. 1988 Oct;56(5):748–53. PMID: WOS:A1988Q401700016. [PubMed: 3192792]

Bastien CH, Morin CM, Ouellet MC, et al. Cognitive-behavioral therapy for insomnia: comparison of individual therapy, group therapy, and telephone consultations. J Consult Clin Psychol. 2004 Aug;72(4):653–9. [PubMed: 15301650]

Holmqvist M, Vincent N, Walsh K. Web-vs telehealth-based delivery of cognitive behavioral therapy for insomnia: a randomized controlled trial. Sleep Med. 2014;15(2):187–95. [PubMed: 24461370]

Lancee J, Sorbi MJ, Eisma MC, et al. The effect of support on internet-delivered treatment for Insomnia: Does baseline depression severity matter? Behav. 2014 July;45(4):507–16. [PubMed: 24912463]

Lancee J, van den Bout J, Sorbi MJ, et al. Motivational support provided via email improves the effectiveness of internet-delivered self-help treatment for insomnia: a randomized trial. Behav Res Ther. 2013 Dec;51(12):797–805. [PubMed: 24121097]

Rybarczyk B, Mack L, Harris JH, et al. Testing two types of self-help CBT-I for insomnia in older adults with arthritis or coronary artery disease. Rehabil Psychol. 2011 Nov;56(4):257–66. [PubMed: 22121936]

Pech M, O'Kearney R. A randomized controlled trial of problem-solving therapy compared to cognitive therapy for the treatment of insomnia in adults. Sleep. 2013 May 01;36(5):739–49. [PMC free article: PMC3624829] [PubMed: 23633757]

Rybarczyk B, Lopez M, Schelble K, et al. Home-based video CBT for comorbid geriatric insomnia: a pilot study using secondary data analyses. Behav Sleep Med. 2005;3(3):158–75. [PubMed: 15984917]

Jansson-Frojmark M, Lind M, Sunnhed R. Don't worry, be constructive: a randomized controlled feasibility study comparing behaviour therapy singly and combined with constructive worry for insomnia. Br J Clin Psychol. 2012 Jun;51(2):142–57. [PubMed: 22574800]

Riley WT, Mihm P, Behar A, et al. A computer device to deliver behavioral interventions for insomnia. Behav Sleep Med. 2010;8(1):2–15. [PubMed: 20043245]

Krystal A, Walsh J, Laska E, et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep. 2003;26(7):793–9. [PubMed: 14655910]

Walsh JK, Krystal AD, Amato DA, et al. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep. 2007 Aug;30(8):959–68. [PMC free article: PMC1978384] [PubMed: 17702264]

Zammit GK, McNabb LJ, Caron J, et al. Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia. Curr Med Res Opin. 2004 Dec;20(12):1979–91. [PubMed: 15701215]

Elie R, Ruther E, Farr I, et al. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. J Clin Psychiatry. 1999;60(8):536–44. [PubMed: 10485636]

Fry J, Scharf M, Mangano R, et al. Zaleplon improves sleep without producing rebound effects in outpatients with insomnia. Int Clin Psychopharmacol. 2000;15(3):141–52. [PubMed: 10870872]

Lahmeyer H, Wilcox C, Kann J, et al. Subjective efficacy of zolpidem in outpatients with chronic insomnia: double blind comparison with placebo. Clin Drug Invest. 1997;13:134–44.

Scharf M, Roth T, Vogel G, et al. A multicenter placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. J Clin Psychiatry. 1994;55(5):192–9. [PubMed: 8071269]

Randall S, Roehrs TA, Roth T. Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study. Sleep. 2012 Nov;35(11):1551–7. [PMC free article: PMC3466802] [PubMed: 23115404]

Allain H, Arbus L, Schuck S. Efficacy and safety of zolpidem administered as needed in primary insomnia: results of a double-blind, placebo-controlled study. Clin Drug Invest. 2001;21(6):391–4000.

Perlis ML, McCall WV, Krystal AD, et al. Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia. J Clin Psychiatry. 2004 Aug;65(8):1128–37. [PubMed: 15323600]

Walsh J. Zolpidem “as needed” for the treatment of primary insomnia: a double-blind, placebo-controlled study. Sleep Med Rev. 2002;6:S7–11. [PubMed: 12607571]

Roth T, Krystal A, Steinberg FJ, et al. Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study. Sleep. 2013 Feb;36(2):189–96. [PMC free article: PMC3543068] [PubMed: 23372266]

Krystal AD, Erman M, Zammit GK, et al. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep. 2008 Jan;31(1):79–90. [PMC free article: PMC2225552] [PubMed: 18220081]

Ancoli-Israel S, Krystal AD, McCall WV, et al. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia. Sleep. 2010 Feb;33(2):225–34. [PMC free article: PMC2817909] [PubMed: 20175406]

Leppik I, Roth-Schechter G, Gray G, et al. Double blind, placebo controlled comparison of zolpidem, triazolam, and temazepam in elderly patients with insomnia. Drug Dev Res. 1997;40:230–8.

Goforth HW, Preud'homme XA, Krystal AD. A randomized, double-blind, placebo-controlled trial of eszopiclone for the treatment of insomnia in patients with chronic low back pain. Sleep. 2014 Jun;37(6):1053–60. [PMC free article: PMC4015379] [PubMed: 24882900]

Wade AG, Crawford G, Ford I, et al. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response. Curr Med Res Opin. 2011 Jan;27(1):87–98. [PubMed: 21091391]

Wade AG, Ford I, Crawford G, et al. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety. BMC Med. 2010;8:51. [PMC free article: PMC2933606] [PubMed: 20712869]

Kuriyama A, Honda M, Hayashino Y. Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis. Sleep Med. 2014;15(4):385–92. [PubMed: 24656909]

Mayer G, Wang-Weigand S, Roth-Schechter B, et al. Efficacy and Safety of 6-Month Nightly Ramelteon Administration in Adults with Chronic Primary Insomnia. Sleep. 2009 Mar;32(3):351–60. PMID: WOS:000263705500009. [PMC free article: PMC2647789] [PubMed: 19294955]

Uchimura N, Ogawa A, Hamamura M, et al. Efficacy and safety of ramelteon in Japanese adults with chronic insomnia: a randomized, double-blind, placebo-controlled study. Expert rev. 2011 Feb;11(2):215–24. [PubMed: 21306209]

Zammit G, Erman M, Wang-Weigand S, et al. Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia. J Clin Sleep Med. 2007 Aug 15;3(5):495–504. [Erratum appears in J Clin Sleep Med. 2007 Oct 15;3(6):table of contents], [Erratum appears in J Clin Sleep Med. 2008 Oct 15;4(5):table of contents] [PMC free article: PMC1978328] [PubMed: 17803013]

Roth T, Seiden D, Sainati S, et al. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia. Sleep Med. 2006 Jun;7(4):312–8. PMID: WOS:000238523200003. [PubMed: 16709464]

Hajak G, Rodenbeck A, Voderholzer U, et al. Doxepin in the treatment of primary insomnia - a placebo-controlled, double-blind, polysomnographic study. J Clin Psychiatry. 2001;62(6):453–63. [PubMed: 11465523]

Krystal AD, Lankford A, Durrence HH, et al. Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia. Sleep. 2011 Oct;34(10):1433–42. [PMC free article: PMC3174845] [PubMed: 21966075]

Krystal AD, Durrence HH, Scharf M, et al. Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia. Sleep. 2010 Nov;33(11):1553–61. PMID: WOS:000285212600019. [PMC free article: PMC2954705] [PubMed: 21102997]

Lankford A, Rogowski R, Essink B, et al. Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia. Sleep Med. 2012 Feb;13(2):133–8. PMID: WOS:000301695500003. [PubMed: 22197474]

Michelson D, Snyder E, Paradis E, et al. Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet neurol. 2014 May;13(5):461–71. [PubMed: 24680372]

Herring WJ, Connor KM, Ivgy-May N, et al. Suvorexant in Patients with Insomnia: Results from Two 3-Month Randomized Controlled Clinical Trials. Biol Psychiatry. 2014 [PubMed: 25526970]

Herring WJ, Snyder E, Budd K, et al. Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. Neurology. 2012 Dec 4;79(23):2265–74. [PubMed: 23197752]

Voshaar RCO, Van Balkom AJLM, Zitman FG. Zolpidem is not superior to temazepam with respect to rebound insomnia: A controlled study. Eur Neuropsychopharmacol. 2004 August;14(4):301–6. [PubMed: 15163440]

Ancoli-Israel S, Richardson GS, Mangano RM, et al. Long-term use of sedative hypnotics in older patients with insomnia. Sleep Med. 2005 Mar;6(2):107–13. [PubMed: 15716214]

Chen PL, Lee WJ, Sun WZ, et al. Risk of dementia in patients with insomnia and long-term use of hypnotics: a population-based retrospective cohort study. PLoS ONE. 2012;7(11):e49113. [PMC free article: PMC3492301] [PubMed: 23145088]

Huang CY, Chou FH, Huang YS, et al. The association between zolpidem and infection in patients with sleep disturbance. J Psychiatr Res. 2014 Jul;54:116–20. [PubMed: 24721551]

Jaussent I, Ancelin ML, Berr C, et al. Hypnotics and mortality in an elderly general population: a 12-year prospective study. BMC Med. 2013;11:212. [PMC free article: PMC3849429] [PubMed: 24070457]

Kang DY, Park S, Rhee CW, et al. Zolpidem use and risk of fracture in elderly insomnia patients. J Prev Med Pub Health. 2012 Jul;45(4):219–26. [PMC free article: PMC3412984] [PubMed: 22880153]

Kripke DF, Langer RD, Kline LE. Hypnotics' association with mortality or cancer: a matched cohort study. Bmj Open. 2012;2(1) PMID: WOS:000315037200085. [PMC free article: PMC3293137] [PubMed: 22371848]

Lai MM, Lin CC, Lin CC, et al. Long-Term Use of Zolpidem Increases the Risk of Major Injury: A Population-Based Cohort Study. Mayo Clinic Proceedings. 2014 May;89(5):589–94. PMID: WOS:000335560400005. [PubMed: 24684782]

Richardson GS, Zammit G, Wang-Weigand S, et al. Safety and subjective sleep effects of ramelteon administration in adults and older adults with chronic primary insomnia: a 1-year, open-label study. J Clin Psychiatry. 2009 Apr;70(4):467–76. [PubMed: 19284927]

Roth T, Walsh JK, Krystal A, et al. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Med. 2005 Nov;6(6):487–95. PMID: WOS:000233577000003. [PubMed: 16230048]

Schlich D, L'Heritier C, Coquelin JP, et al. Long-term treatment of insomnia with zolpidem: a multicentre general practitioner study of 107 patients. J Int Med Res. 1991 May-Jun;19(3):271–9. [Erratum appears in J Int Med Res 1993 Nov-Dec;21(6):346] [PubMed: 1670039]

Uchiyama M, Hamamura M, Kuwano T, et al. Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomnia. Sleep Med. 2011 Feb;12(2):127–33. [PubMed: 21277255]

Wang PS, Bohn RL, Glynn RJ, et al. Zolpidem use and hip fractures in older people. J Am Geriatr Soc. 2001 Dec;49(12):1685–90. [PubMed: 11844004]

Hachul H, Garcia TKP, MacIel AL, et al. Acupuncture improves sleep in postmenopause in a randomized, double-blind, placebo-controlled study. Climacteric. 2013 February;16(1):36–40. [PubMed: 22943846]

Huo ZJ, Guo J, Li D. Effects of acupuncture with meridian acupoints and three Anmian acupoints on insomnia and related depression and anxiety state. Chin J Integr Med. 2013 Mar;19(3):187–91. [PubMed: 22903446]

Cooper KL, Relton C. Homeopathy for insomnia: summary of additional RCT published since systematic review. Sleep Med Rev. 2010 Dec;14(6):411. [PubMed: 20817511]

Cooper KL, Relton C. Homeopathy for insomnia: a systematic review of research evidence. Sleep Med Rev. 2010 Oct;14(5):329–37. [PubMed: 20223686]

Harrison CC, Solomon EM, Pellow J. The effect of a homeopathic complex on psychophysiological onset insomnia in males: a randomized pilot study. Altern Ther Health Med. 2013 Sep-Oct;19(5):38–43. [PubMed: 23981403]

Taibi DM, Landis CA, Petry H, et al. A systematic review of valerian as a sleep aid: safe but not effective. Sleep Med Rev. 2007 Jun;11(3):209–30. [PubMed: 17517355]

Friedman L, Zeitzer JM, Kushida C, et al. Scheduled bright light for treatment of insomnia in older adults. J Am Geriatr Soc. 2009 Mar;57(3):441–52. [PMC free article: PMC2743069] [PubMed: 19187411]

Kirisoglu C, Guilleminault C. Twenty minutes versus forty-five minutes morning bright light treatment on sleep onset insomnia in elderly subjects. J Psychosom Res. 2004 May;56(5):537–42. [PubMed: 15172210]

Abbasi B, Kimiagar M, Sadeghniiat K, et al. The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. Journal of Research in Medical Sciences. 2012;17(12):1161–9. [PMC free article: PMC3703169] [PubMed: 23853635]

Hachul H, Brandao LC, D'Almeida V, et al. Isoflavones decrease insomnia in postmenopause. Menopause. 2011 Feb;18(2):178–84. [PubMed: 20729765]

Lin Y, Wang XY, Ye R, et al. Efficacy and safety of Wuling capsule, a single herbal formula, in Chinese subjects with insomnia: a multicenter, randomized, double-blind, placebo-controlled trial. J Ethnopharmacol. 2013 Jan 9;145(1):320–7. [PubMed: 23178661]

Zick SM, Wright BD, Sen A, et al. Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: a randomized placebo-controlled pilot study. BMC Altern Med. 2011;11:78. [PMC free article: PMC3198755] [PubMed: 21939549]

Morin CM, Vallieres A, Guay B, et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. Jama. 2009 May 20;301(19):2005–15. [PMC free article: PMC3050624] [PubMed: 19454639]

Wang W-d, Li G-x, Hong L, et al. Low Resistance Thought Induction Sleep-regulating Technique (TIP3-2) combined with medication for primary insomnia: A randomized controlled trial. Int J Behav Med. 2014 Aug;21(4):618–28. [PubMed: 24875654]

Guo J, Wang LP, Liu CZ, et al. Efficacy of acupuncture for primary insomnia: A randomized controlled clinical trial. Evidence-based Complementary and Alternative Medicine. 2013;2013(163850) [PMC free article: PMC3789397] [PubMed: 24159338]

Kripke DF. Greater incidence of depression with hypnotic use than with placebo. BMC Psychiatry. 2007 Aug;7 PMID: WOS:000250031000001. [PMC free article: PMC1994947] [PubMed: 17711589]

Kripke DF. Possibility that certain hypnotics might cause cancer in skin. J Sleep Res. 2008 Sep;17(3):245–50. [PubMed: 18844818]

Glass J, Lanctot KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. Bmj. 2005 Nov 19;331(7526):1169. [PMC free article: PMC1285093] [PubMed: 16284208]

Weich S, Pearce HL, Croft P, et al. Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study. Bmj. 2014;348:g1996. [PMC free article: PMC3959619] [PubMed: 24647164]